We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current C1NC34 market cap is 185.73B. The company's latest EPS is USD 5.0580 and P/E is 11.85.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 38.04B | 39.46B | 40.41B | 39.84B | 42.02B |
Operating Income | 1.18B | -143M | 1.12B | 1.23B | 665M |
Net Income | 469M | 45M | 1.16B | 1.15B | 713M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 74.64B | 111.12B | 125.98B | 144.55B | 154B |
Operating Income | 1.78B | 3.08B | 1.78B | 3.64B | 3.46B |
Net Income | 1.32B | 1.81B | 1.35B | 1.2B | 2.7B |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 84.38B | 84.64B | 82.62B | 83.14B | 82.35B |
Total Liabilities | 58.97B | 58.69B | 55.56B | 55.68B | 54.94B |
Total Equity | 25.4B | 25.94B | 27.05B | 27.44B | 27.4B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 40.99B | 68.72B | 78.38B | 76.87B | 84.64B |
Total Liabilities | 28.3B | 42.76B | 51.35B | 52.63B | 58.69B |
Total Equity | 12.66B | 25.89B | 26.94B | 24.18B | 25.94B |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 7.84B | 8.05B | -456M | 1.72B | 741M |
Investing | -242M | -1.19B | 852M | -315M | -1.15B |
Financing | -1.46B | -1.66B | 23M | -1.15B | -2.39B |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 1.48B | 5.5B | 4.21B | 6.26B | 8.05B |
Investing | -1.53B | -6.96B | -3.3B | -2.92B | -1.19B |
Financing | 6.83B | 260M | 1.36B | -4.2B | -1.66B |
Market Cap | 185.73B |
Price to Earnings Ratio | 11.85 |
Price to Sales Ratio | 0.21 |
Price to Cash Ratio | 1.86 |
Price to Book Ratio | 1.23 |
Dividend Yield | - |
Shares Outstanding | 534.2M |
Average Volume (1 week) | 2 |
Average Volume (1 Month) | 5 |
52 Week Change | -5.41% |
52 Week High | 452.76 |
52 Week Low | 335.58 |
Spread (Intraday) | 4.2 (1.19%) |
Company Name | Centene Corp. |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.centene.com |
Industry | hospital & medical svc plans (6324) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions